Human development

Sierra Metals Announces New Vice President, Health & Safety

Retrieved on: 
Monday, March 4, 2024

Sierra Metals Inc. (TSX: SMT | OTCQX: SMTSF) (“Sierra Metals” or the “Company”) is pleased to announce the appointment of Mr. Astolfo Romero as Vice President, Health & Safety effective March 1, 2024 replacing Mr. Felix Guerra who is retiring after a very successful career in the mining industry.

Key Points: 
  • Sierra Metals Inc. (TSX: SMT | OTCQX: SMTSF) (“Sierra Metals” or the “Company”) is pleased to announce the appointment of Mr. Astolfo Romero as Vice President, Health & Safety effective March 1, 2024 replacing Mr. Felix Guerra who is retiring after a very successful career in the mining industry.
  • Ernesto Balarezo, CEO of Sierra Metals, commented, “We are very excited to have Astolfo join Sierra.
  • As a Postgraduate Teacher he received his Master's degree in Mining Management at GERENS and Pontificia Universidad Catolica del Peru.
  • Before joining Sierra, over the last 11 years, Mr. Romero served in multiple management positions in Volcan Compania Minera (Glencore) in areas such as Health & Safety, Operational Excellence, and Human Development.

The Foundation for the National Institutes of Health Launches First Public-Private Partnership for Early Detection of Preeclampsia

Retrieved on: 
Monday, February 12, 2024

The Foundation for the National Institutes of Health (FNIH) today announces the launch of a new public-private partnership to develop tools to identify pregnant women at high risk of early-onset preeclampsia.

Key Points: 
  • The Foundation for the National Institutes of Health (FNIH) today announces the launch of a new public-private partnership to develop tools to identify pregnant women at high risk of early-onset preeclampsia.
  • Preeclampsia is a serious pregnancy-related hypertensive disorder that can lead to maternal and neonatal deaths and long-term negative health outcomes.
  • The disorder is becoming more prevalent in the United States, with women of color more likely to be affected and experience poor outcomes.
  • Currently, preeclampsia risk is determined early in pregnancy using a combination of maternal medical history and clinical risk factors.

HUMAN CAPABILITY INITIATIVE CONVENES POWERHOUSE LINE-UP OF SPEAKERS FOR EXPERT-LED PLATFORM IN RIYADH

Retrieved on: 
Wednesday, January 31, 2024

150+ prominent speakers encompassing government officials, business & education leaders, entrepreneurs and experts will convene in Riyadh for the Human Capability Initiative

Key Points: 
  • 150+ prominent speakers encompassing government officials, business & education leaders, entrepreneurs and experts will convene in Riyadh for the Human Capability Initiative
    The breadth of high-level speakers and 6000+ global attendees demonstrate the collective impetus to unleash human capabilities potential through fostering intellectual dialogue in Riyadh.
  • RIYADH, Saudi Arabia, Jan. 31, 2024 /PRNewswire/ -- The Human Capability Initiative (HCI) is thrilled to announce key speakers for its forthcoming event taking place from the 28th – 29th February, 2024.
  • Bringing together luminaries from diverse sectors and backgrounds, these eminent industry leaders and experts will spearhead dynamic discussions centred around Human Capability Development (HCD) to prepare individuals for the challenges and opportunities of the future.
  • HCI's speaker line-up showcases the collective impetus across sectors to contribute to a sustainable global agenda that pioneers solutions for human capability development.

HUMAN CAPABILITY INITIATIVE CONVENES POWERHOUSE LINE-UP OF SPEAKERS FOR EXPERT-LED PLATFORM IN RIYADH

Retrieved on: 
Wednesday, January 31, 2024

150+ prominent speakers encompassing government officials, business & education leaders, entrepreneurs and experts will convene in Riyadh for the Human Capability Initiative

Key Points: 
  • 150+ prominent speakers encompassing government officials, business & education leaders, entrepreneurs and experts will convene in Riyadh for the Human Capability Initiative
    The breadth of high-level speakers and 6000+ global attendees demonstrate the collective impetus to unleash human capabilities potential through fostering intellectual dialogue in Riyadh.
  • RIYADH, Saudi Arabia, Jan. 31, 2024 /PRNewswire/ -- The Human Capability Initiative (HCI) is thrilled to announce key speakers for its forthcoming event taking place from the 28th – 29th February, 2024.
  • Bringing together luminaries from diverse sectors and backgrounds, these eminent industry leaders and experts will spearhead dynamic discussions centred around Human Capability Development (HCD) to prepare individuals for the challenges and opportunities of the future.
  • HCI's speaker line-up showcases the collective impetus across sectors to contribute to a sustainable global agenda that pioneers solutions for human capability development.

Daré Bioscience and Premier Research Extend Strategic Partnership to Accelerate the Clinical Development of Daré’s Novel Women’s Health Programs

Retrieved on: 
Monday, November 20, 2023

The agreement was originally established with Health Decisions, Inc., which was acquired by Premier Research in 2021.

Key Points: 
  • The agreement was originally established with Health Decisions, Inc., which was acquired by Premier Research in 2021.
  • “In 2020, Daré and Premier Research conducted a successful Phase 3 clinical study of XACIATO™ (clindamycin phosphate) vaginal gel 2% despite the challenges posed by a global pandemic.
  • “Premier Research is thrilled to renew this partnership and continue our successful work with Daré,” said Michael Arlotto, Ph.D., Chief Operating Officer of Premier Research.
  • “This partnership underscores our joint commitment to advancing women’s health by supporting efforts to include women in clinical research and bring novel products to market.

Tiny Love Emphasizes Its 6 Developmental Wonders by Helping Families Create Moments of Wonder for Their Little Ones

Retrieved on: 
Tuesday, November 28, 2023

FOXBOROUGH, Mass., Nov. 28, 2023 /PRNewswire/ -- The first year of a baby's life is filled with crucial cognitive milestones, from understanding language and exploring their surroundings to learning how to interact with loved ones. In line with this, Tiny Love, a pioneer in infant developmental products and the first to conceive and patent the Gymini — a play mat with attached arches — has been a global leader for over 30 years. With a mission to support families from newborns to toddlerhood, Tiny Love reinforced its 6 Developmental Wonders™ at an exclusive event in New York City. The brand leaned into the importance of sensory and cognitive play for today's infants in partnership with Erin O'Connor, a distinguished professor at New York University's Steinhardt School of Culture, Education, and Human Development, Chief of Education at Cooper, and co-host of the Parenting Understood podcast.

Key Points: 
  • With a mission to support families from newborns to toddlerhood, Tiny Love reinforced its 6 Developmental Wonders™ at an exclusive event in New York City.
  • "Tiny Love takes pride in creating products that are designed to stimulate your baby's senses, foster development, encourage bonding, and create moments of wonder throughout their first year of life," said Natalie Thompson, Tiny Love Brand Marketing Lead.
  • "Tiny Love shares my passion for early childhood development and it's wonderful to help educate parents about their 6 Developmental Wonders™."
  • To learn more about Tiny Love's 6 Developmental Wonders™ and how parents can create Moments of Wonder with their little ones, visit https://www.maxicosi.com/us-en/about-tiny-love .

Daré Bioscience Reports Third Quarter 2023 Financial Results and Provides Company Update

Retrieved on: 
Thursday, November 9, 2023

SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the quarter ended September 30, 2023 and provided a company update.

Key Points: 
  • ET
    SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today reported financial results for the quarter ended September 30, 2023 and provided a company update.
  • XACIATO™ provides a new therapeutic option for the millions of women suffering from bacterial vaginosis in the U.S.
  • Financial Highlights for the Quarter ended September 30, 2023
    Cash and cash equivalents: $13.8 million at September 30, 2023.
  • Daré will host a conference call and live webcast today, November 9, 2023, at 4:30 p.m. Eastern Time to review financial results for the quarter ended September 30, 2023 and to provide a company update.

RESOURCES FOR HUMAN DEVELOPMENT AND THE CITY OF NEW ORLEANS UNVEIL LIFESAVING MOBILE CRISIS INTERVENTION UNIT TODAY!

Retrieved on: 
Wednesday, October 25, 2023

NEW ORLEANS, Oct. 25, 2023 /PRNewswire/ -- The New Orleans Mobile Crisis Intervention Unit (MCIU) isn't just a program; it's a lifeline.

Key Points: 
  • NEW ORLEANS, Oct. 25, 2023 /PRNewswire/ -- The New Orleans Mobile Crisis Intervention Unit (MCIU) isn't just a program; it's a lifeline.
  • With tangible results, it's reshaping New Orleans' mental health landscape, and reducing law enforcement interventions and emergency room visits while making the streets safer.
  • The New Orleans MCIU consists of a team of trained mental health professionals who respond to mental health emergencies in the city.
  • New Orleans MCIU is integrated through OPCD (the local 911 system) to respond to non-violent behavioral health crisis calls 24/7/365.

Bulat Utemuratov Foundation signs MOU with world-leading autism expert Connie Kasari

Retrieved on: 
Wednesday, September 27, 2023

Partnership will help children with autism across Kazakhstan, using JASPER methodology

Key Points: 
  • Partnership will help children with autism across Kazakhstan, using JASPER methodology
    Announcement made at Foundation's 5th Autism Conference, bringing together experts
    ASTANA, Kazakhstan, Sept. 27, 2023 /PRNewswire/ -- The Bulat Utemuratov Foundation announces that it has signed a three-year Memorandum of Intent for Cooperation and Interaction with world-renowned autism spectrum disorder expert Dr. Connie Kasari.
  • It will pave the way for Kazakhstan to become a leading regional center for autism research, training and treatment.
  • The partnership was announced at the Bulat Utemuratov Foundation's 5th International "Asyl Miras.
  • Autism.

Bulat Utemuratov Foundation signs MOU with world-leading autism expert Connie Kasari

Retrieved on: 
Wednesday, September 27, 2023

Partnership will help children with autism across Kazakhstan, using JASPER methodology

Key Points: 
  • Partnership will help children with autism across Kazakhstan, using JASPER methodology
    Announcement made at Foundation's 5th Autism Conference, bringing together experts
    ASTANA, Kazakhstan, Sept. 27, 2023 /PRNewswire/ -- The Bulat Utemuratov Foundation announces that it has signed a three-year Memorandum of Intent for Cooperation and Interaction with world-renowned autism spectrum disorder expert Dr. Connie Kasari.
  • It will pave the way for Kazakhstan to become a leading regional center for autism research, training and treatment.
  • The partnership was announced at the Bulat Utemuratov Foundation's 5th International "Asyl Miras.
  • Autism.